PAMP
SLNO

Polar Asset Management Partners’s Soleno Therapeutics SLNO Stock Holding History

Polar Asset Management Partners’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-125,400
Closed -$5.64M – 712
2024
Q4 		$5.64M Buy
125,400
+93,800
+297% +$4.86M 0.07% 213
2024
Q3 		$1.6M Sell
31,600
-42,900
-58% -$2.05M 0.03% 363
2024
Q2 		$3.04M Buy
+74,500
New +$3.16M 0.06% 269

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Polar Asset Management Partners's SLNO Position: Q1 2025 in Review

Polar Asset Management Partners sold out of Soleno Therapeutics (SLNO) in Q1 2025, closing a stake of 125,400 shares — an estimated $5.64M sold.

Polar Asset Management Partners first reported a position in SLNO in Q2 2024 and held it in 3 quarters. The position peaked at $5.64M in Q4 2024. 217 funds tracked by Wall St. Rank hold SLNO as of Q1 2025.

  • Polar Asset Management Partners reported no remaining Soleno Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 125,400 Soleno Therapeutics shares in Q1 2025, an estimated $5.64M.
  • Polar Asset Management Partners first reported a position in Soleno Therapeutics in Q2 2024 and held it in 3 quarters.
  • Polar Asset Management Partners's Soleno Therapeutics position peaked at $5.64M in Q4 2024.
  • 217 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2025.

Based on Polar Asset Management Partners's 13F filing for Q1 2025, filed 15 May 2025.